Everence Capital Management’s Medline Inc MDLN Stock Holding History

Everence Capital Management’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$361K	Buy	+8,113	New	+$358K	0.02%	495

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $3.85B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Everence Capital Management's MDLN Position: Q1 2026 in Review

Everence Capital Management opened a new position in Medline Inc (MDLN) in Q1 2026: 8,113 shares worth $361K. The stake represents 0.02% of the portfolio and ranks #495 among its holdings.

314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

Everence Capital Management held 8,113 shares of Medline Inc worth $361K as of Q1 2026.
Medline Inc was a new Everence Capital Management position in Q1 2026.
Medline Inc made up 0.02% of Everence Capital Management's portfolio in Q1 2026, its #495 holding.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.